Accelevir Diagnostics is Diagnostic Equipment in United States that focus on diagnostic tool business. Founded in 2015. They cover business area such as developer, infectious disease, a core expertise, quantitation, low-frequency viral target, inactive human immunodeficiency virus, diagnostic tool, intact virus, physician, quality, life, critically ill patient, area, major unmet medical and reservoir measurement.
2015
( 9 years old in 2024 )
Diagnostic Tool
-
701 East Pratt Street
Suite 4016
Baltimore, MD 21202
United States
Private
developerinfectious diseasea core expertisequantitationlow-frequency viral targetinactive human immunodeficiency virusdiagnostic toolintact virusphysicianqualitylifecritically ill patientareamajor unmet medical and reservoir measurement
* We use standard office opening hours in near Accelevir Diagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Accelevir Diagnostics is Diagnostic Equipment business from United States that founded in 2015 (9 years old in 2024), Accelevir Diagnostics business is focusing on Diagnostic Tool.
Accelevir Diagnostics headquarter office and corporate office address is located in 701 East Pratt Street Suite 4016 Baltimore, MD 21202 United States.
Accelevir Diagnostics was founded in United States.
In 2024, Accelevir Diagnostics is currently focus on diagnostic tool sector.
Above is snippet of Google Trends for "diagnostic tool" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Accelevir Diagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
